Trial reportInternal and emergency medicine2022
Drug-related emergency department visits: prevalence and risk factors.
Trial report in Internal and emergency medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 44 citations in OpenAlex.
- Trial
- Where do people obtain side effect information? Results from a census-matched U.S. national survey.Exploratory research in clinical and social pharmacy · 2026Article
- Proposed ICD-10 framework for identifying emergency department visits that may be impacted by community pharmacy care clinics.International journal of clinical pharmacy · 2026Article
- Managing medications together: a qualitative study of collaboration between primary and secondary caregivers of older adults.BMC geriatrics · 2026Article
- Navigating safety in practice: a qualitative study of how health care personnel organize medication management in Norwegian home care services.BMC health services research · 2026Article
- Promoting Nordic 'Green Care Practices'.Scandinavian journal of primary health care · 2025Article
- Drug-related emergency department visits in Qatar: a prospective cohort study.BMC emergency medicine · 2025Observational
- Emergency Department Reconsultations After a Secondary Prevention Bundle for Medication-Related Problems: A Retrospective Cohort Study.Journal of clinical medicine · 2025Article
- Impact of clinical pharmacist involvement on emergency department physicians' work-time distribution: a comparative analysis.Therapeutic advances in drug safety · 2025Article
- Drug-related emergency department visits: external validation of an assessment tool in a general emergency department population.International journal of clinical pharmacy · 2024Article
- How Do Pharmacists Distribute Their Work Time during a Clinical Intervention Trial?-A Time and Motion Study.Pharmacy (Basel, Switzerland) · 2024Article
- Antiseizure adverse drug reaction and associated factors among epileptic patients at Jimma Medical Center: a prospective observational study.Scientific reports · 2024Observational
- A four-way patient search method for the retrospective identification of poisoning patients.Scientific reports · 2024Article
- Health professionals' experience and perceived obstacles with managing patients' medication information in Norway: cross-sectional survey.BMC health services research · 2024Article
- Improving Emergency Department Visit Risk Prediction: Exploring the Operational Utility of Applied Patient Portal Messages.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024Article
- Completeness of medication information in admission notes from emergency departments.BMC health services research · 2023Article
- Evaluation of a multifaceted medication review in older patients in the outpatient setting: a before-and-after study.International journal of clinical pharmacy · 2023Article
- Development and validation of a new non-disease-specific survey tool to assess self-reported adherence to medication.Frontiers in pharmacology · 2022Article
- Prevalence and predictors of medication-related emergency department visit in older adults: A multicenter study linking national claim database and hospital medical records.Frontiers in pharmacology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study aimed to investigate the prevalence of drug-related emergency department (ED) visits and associated risk factors. This retrospective cohort study was conducted in the ED, Diakonhjemmet Hospital, Oslo, Norway. From April 2017 to May 2018, 402 patients allocated to the intervention group in a randomized controlled trial were included in this sub-study. During their ED visit, these patients received medication reconciliation and medication review conducted by study pharmacists, in addition to standard care. Retrospectively, an interdisciplinary team assessed the reconciled drug list and identified drug-related issues alongside demographics, final diagnosis, and laboratory tests for all patients to determine whether their ED visit was drug-related. The study population's median age was 67 years (IQR 27, range 19-96), and patients used a median of 4 regular drugs (IQR 6, range 0-19). In total, 79 (19.7%) patients had a drug-related ED visits, and identified risk factors were increasing age, increasing number of regular drugs and medical referral reason. Adverse effects (72.2%) and non-adherence (16.5%) were the most common causes of drug-related ED visits. Antithrombotic agents were most frequently involved in drug-related ED visits, while immunosuppressants had the highest relative frequency. Only 11.4% of the identified drug-related ED visits were documented by physicians during ED/hospital stay. In the investigated population, 19.7% had a drug-related ED visit, indicating that drug-related ED visits are a major concern. If not recognized and handled, this could be a threat against patient safety. Identified risk factors can be used to identify patients in need of additional attention regarding their drug list during the ED visit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.